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Abstract
Purpose This qualitative study aimed to identify hematopoietic stem cell transplantation (HSCT) survivors’ (1) work percep-
tions; (2) barriers to and facilitators of return to work (RTW); and (3) possible solutions to improve RTW.
Method Fifteen patients treated with HSCT 1–5 years ago participated in face-to-face semi-structured interviews. Interviews
were analyzed following the steps of thematic content analyses.
Results RTWwas often characterized as a complex and prolonged trajectory, and it was frequently incomplete in working hours,
tasks, and/or responsibilities. Work perceptions varied between patients; most valued work as positive, but some also reported a
decline in work capacity and/or in importance. Perceived barriers included the duration and side effects of cancer treatment, the
presence of comorbidity and poor health before diagnosis, having difficulties commuting and doing household tasks. Perceived
facilitators were financial incentives, keeping in touch with the workplace, support of other patients and family, and looking after
one’s health. Proposed solutions to improve RTW included discussing RTW at the hospital, enhanced employer support,
improved accessibility of rehabilitation programs, and more information about the consequences of being sick-listed.
Conclusions Many HSCT survivors value work as important and they are motivated to RTW. Insight in work perceptions, RTW
barriers, and solutions might help researchers, healthcare professionals, and employers to develop and/or tailor individualized
multidisciplinary care to facilitate RTW.
Keywords Hematopoietic stem cell transplantation . Hematologicmalignancy . Return to work (RTW) . Qualitative research
Introduction
Hematopoietic stem cell transplantation (HSCT) has im-
proved the survival of patients with various hematologic
malignancies [1]. However, this aggressive type of treat-
ment is frequently associated with short- and long-term
medical complications [1–3], physical and psychological
symptoms [2, 4], and reduced quality of life (QoL) [4, 5].
Not surprisingly, a substantial proportion of HSCT survi-
vors does not, or only partially, return to work (RTW)
[6–13]. A previous study found for instance that only
36% of the HSCT survivors who worked full-time before
transplant had returned to full-time work 1 year after
transplant [8], and this proportion had increased to 60%
after 5 years [8]. The same study showed that 36% of the
HSCT survivors working full-time 3 years after transplant
reported ongoing work-related limitations with a dimin-
ished ability to accomplish as much at work compared
with the pre-illness situation [8]. Similarly, in a Swedish
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study, approximately 40% of the patients that were on
average 10 years post-transplant reported a reduced phys-
ical work capacity [9].
Improving sustainable RTW might improve Qol [14,
15]. Previous reviews in which the experiences with
work of patients with various types of cancer were eval-
uated reported that (return to) work may restore a sense
of normalcy and/or a sense of the former self, and pro-
vide financial security, distraction [15, 16], and social
interaction [16].
Currently, only limited data are available on the atti-
tudes toward and experiences with RTW of HSCT survi-
vors. Recently, an American qualitative study evaluated
the long-term experiences with work and finances among
patients treated with autologous stem cell transplantation
[17]. Notable were the reported financial challenges and
health insurance difficulties [17]. Furthermore, a previous
Australian qualitative study explored the survivorship and
RTW experiences of patients treated for hematologic ma-
lignancies, of whom half were treated with HSCT [18].
This study focused on patients who faced major problems
with returning to work, the facilitators of successful RTW
and recommendations for supportive care organizations,
and to a lesser extent on perceived problems while being
at work [18]. The findings of these studies, notwithstand-
ing their importance, may not be generalizable to other
countries given the country-specific laws and regulations.
In the Netherlands, both patients and employers are re-
sponsible for RTW. During the first 2 years of sick-leave,
patients cannot be fired because of illness and they re-
ceive at least 70% of their salary. Subsequently, patients
are assessed for disability pension [19].
Given the scarcity of literature on this topic, more
research on HSCT survivors’ experiences with their
RTW is warranted. This will aid the development of in-
terventions supporting survivors to successfully RTW.
Therefore, this qualitative study aimed to identify
HSCT survivors’ (1) (return to) work perceptions; (2)
barriers to and facilitators of RTW; and (3) possible so-
lutions to improve RTW.
Methods
We conducted 15 face-to-face semi-structured interviews
between March and May 2014 and followed the consoli-
dated criteria for reporting qualitative research (COREQ)
[20]. Ethical approval from the Medical Ethics Committee
of the Academic Medical Center (AMC) was sought, but
this Committee decided that an extensive test on ethical
and juridical aspects was unnecessary (W13_033). The
Medical Ethical Committee had no objection to the exe-
cution of this study.
Patient recruitment and study procedures
Patients were recruited from the outpatient clinic of the
hematology department of an academic hospital using a
convenience sampling process. They were eligible for par-
ticipation if they were: (1) treated with HSCT for a hema-
tologic malignancy 1–5 years earlier; (2) aged between 18
and 60 years at the time of the HSCT; (3) working at least
12 h per week in the year prior to the HSCT; (4) fluent in
Dutch; (5) in remission since the HSCT; and (6) having
no severe physical or mental comorbidity at time of the
interview. Recruitment was stopped after 15 interviews.
We determined this sample size a priori based on our
experience with reaching data saturation after inclusion
of 12 patients in a previous qualitative study regarding
barriers to and facilitators of RTW of breast cancer survi-
vors [21], assuming that we would reach data saturation
with 10–15 patients.
Potentially eligible patients were informed about the study
by their treating hematologist. Hereafter, SK (a female master
student) contacted these patients by telephone to re-establish
eligibility and willingness to participate. If patients fulfilled
the criteria, an appointment for the interview was made. Prior
to the interview, patients were asked to fill out a short ques-
tionnaire on disease, treatment, and work-related characteris-
tics. The aim of the study, the position of the interviewer, and
the guarantee that the data were handled confidentially were
discussed with each patient. Hereafter, patients gave their writ-
ten informed consent.
The face-to-face semi-structured interviews were audio-re-
corded. Thirteen (87%) patients were interviewed at the out-
patient clinic and two at home. Each interview started with
open-ended questions followed by more specific in-depth
questions on: (1) the diagnosis and treatment and pre-
treatment work situation, (2) work perceptions, (3) perceived
barriers to and facilitators of RTW, and (4) possible solutions
to improve RTW. The topic list was pilot tested in an interview
with a patient with multiple myeloma.
The interviewer (SK) summarized all factors mentioned at
the end of the interview to check for misunderstandings and
completeness.
Analysis
The MAXQDA (Verbi GmbH, Marburg, Germany version
11) qualitative data analysis software package was used to
code the transcripts.
All transcripts were analyzed following a thematic con-
tent analysis approach [22]. First, every transcript was
read to become familiar with the content of the interview.
Second, transcripts were open-coded to identify important
answers to the research questions. The labels of the open
codes represented the transcript as closely as possible. To
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be able to analyze different sub-questions separately, la-
bels could be used in multiple classifications.
Third, to identify the work perceptions, the open codes
were translated into themes (axial coding) and these
themes were divided into four sub-themes (selective cod-
ing): RTW motivation, RTW values, feelings about RTW,
and perceived work ability. The first three themes were
taken from the overview presented by De Jong et al. [23].
For the development of this overview, the experiences and
perceptions of working life of employees with a chronic
disease as reported in 61 publications had been synthe-
sized and categorized in five categories [23].
Fourth, to comprehensively identify barriers to and fa-
cilitators of RTW, the open codes were classified using
the International Classification of Functioning, Disability
and Health (ICF) model developed by the World Health
Organization [24]. The ICF-model enables a comprehen-
sive and transparent analysis, as it describes the interac-
tion between health and disability, body function and
structures, activities and participations, and personal and
environmental factors [24]. Subsequently, open codes
were translated into themes (axial coding) and these
themes were translated into the factors of the core set
for vocational rehabilitation (selective coding) [25].
Fifth, to identify the possible solutions to improve
RTW, open codes were translated into themes. SK per-
formed all five above-mentioned steps. Thereafter, ST re-
peated steps 3 to 5 of the analyses conducted by SK, with
knowledge of the outcome of the analyses done by SK.
ST and SP discussed the final themes until consensus was
reached.
Results
Recruitment was stopped after 15 interviews. Before
reaching this number, 22 patients had been invited, of
whom 7 (32%) did not participate for unknown reasons.
47% of the patients were female, the median age of the
patients was 48 years (range 30–59), 33% had a bache-
lor’s or master’s degree, 73% were married or living to-
gether, and the patients were on average 30 months (range
15–57) post-HSCT (Table 1). The median duration of the
interviews was 38 (range 13–73) minutes.
Work-related characteristics
Twelve patients (80%) had a permanent employment con-
tract before they were diagnosed with cancer, two (13%)
were self-employed, and one (7%) had a temporary em-
ployment contract (Table 2).
RTW process
All patients were sick-listed during the treatment period or
part of it (Table 2). Two patients did not RTW; one patient
was already on sick-leave before cancer diagnosis and was
assessed for a disability pension shortly after HSCT, and for
one patient, the employment contract was not extended. The
RTW process of the remaining 13 patients frequently took
months or years following treatment, was often characterized
by a gradual RTW in hours, workload, workplace tasks, and/
or responsibilities, and was sometimes not or only partly suc-
cessful. The prolonged duration and incompleteness of the
RTW process was illustrated by patient 2 (quote 1, Table 3).
Work perceptions
Most patients were positive about working and were motivat-
ed to RTW. Some patients reported that work had declined in
importance, some reported that their work remained equally
important, and one patient indicated that he now better real-
ized how important work was for him (quote 2, Table 3). RTW
was both associated with positive (e.g., enjoying the work
task) and negative feelings (e.g., not being taken seriously,
not wanting to talk about the disease). Often, patients men-
tioned diminished work ability (Table 4). Patient 2 illustrated
his struggle with the inability to perform his old job tasks
(quote 3, Table 3).
Barriers to and facilitators of RTW
All patients reported several barriers to and facilitators of
RTW across different ICF-domains (Table 5). Many factors
were identified both as barrier to some patients and as facili-
tator to others, mainly depending on the direction of the factor
(e.g., support being absent or present).
Body functions and structure
Identified RTW barriers included impairments resulting from
the long duration of cancer treatment and the slow or insuffi-
cient recovery of the physical (e.g., fatigue, weakened im-
mune system) and mental (i.e., cognitive functioning) impact
of the disease and treatment. In addition, temperament and
personality functions (e.g., being too tough for oneself) were
mentioned as barriers. Absence or recovery of side effects and
temperament and personality functions (e.g., having confi-
dence, being independent) were identified as RTW
facilitators.
Activities and participation
Taking care of household tasks and/or children, and commut-
ing were mentioned as barriers. Perceived facilitators included
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‘fear of losing his/her job,’ or ‘looking after one’s health’ (e.g.,
using psychotherapy or participating in a rehabilitation pro-
gram or sports), see Table 3, quote 4.
Personal factors
Awide variety of personal barriers to and facilitators of RTW
were identified, which can be divided into the following do-
mains: the importance of work, skills/competences (e.g., hav-
ing difficulties with the work load) and coping strategies (e.g.,
having difficulties with accepting limitations, having difficul-
ties with performing job tasks due to fear of infection (quote 5,
Table 3), and having difficulties with RTW insecurity (quote
6, Table 3)).
Personal RTW facilitators included ‘gaining required infor-
mation’ (skills/competences), ‘discuss perceived limitations
with supervisor/colleagues,’ and ‘take the initiative to plan
RTW’ (both coping strategies).
Environmental factors—directly related to work
Specific characteristics of the job content (e.g., only be-
ing able to do the job full-time) and working conditions
(e.g., not having their workplace anymore) were men-
tioned as barriers. In addition, three negative aspects of
employment were pointed out: being fired due to long-
term sick-leave, being self-employed, and difficulties get-
ting back to the previously held position (quote 7,
Table 3).
In addition, either already existing negative work re-
lations or negatively altered relations at the workplace
due to cancer were mentioned as RTW barriers.
Patients mentioned that supervisors and/or colleagues
found it difficult to deal with Bcancer^ at the workplace,
that they experienced insufficient recognition from col-
leagues, no understanding about the (long-term) conse-
quences of HSCT, disagreement about which tasks the
patients were entitled to do, and they experienced diffi-
cult encounters with customers. For instance, patient 5
often had to shake hands with business relations, but
was now unable to do so because of the risk of infec-
tions (quote 8, Table 3).
Job content (e.g., not having physically heavy work) and
work conditions (e.g., being able to work from home) and
aspects of employment (e.g., being able to gradually RTW,
flexibility in working hours, being able to (temporarily) do
less demanding tasks) were also mentioned as facilitators.
The importance of keeping in touch with the supervisor and/
or colleagues was emphasized. Work relations provided sup-
port and understanding and a safe place to return to. Adequate
RTW support from the supervisor, occupational physician,
and human resource management was also identified as
Table 1 Demographics and clinical characteristics of the patients treated with HSCT
Pt Age, years Diagnosis Type of HSCT Intensity of conditioninga,b Chronic GVHDc Months since HSCT
1 ≥ 45 AML Allo Reduced intensity No < 24
2 ≥ 45 ALL Allo Reduced intensity No > 24
3 < 45 AML (relapsed) Allo Myeloablative No < 24
4 < 45 NHL (relapsed) Allo Reduced intensity No > 24
5 ≥ 45 AML Allo Reduced intensity Yes < 24
6 ≥ 45 AML Allo Myeloablative Yes > 24
7 ≥ 45 NK LGL leukemia Allo Reduced intensity No < 24
8 ≥ 45 MM Auto – – > 24
9 < 45 AML Allo Myeloablative Yes > 24
10 < 45 AML Allo Reduced intensity Yes < 24
11 ≥ 45 MM Auto – – < 24
12 < 45 AML Allo Myeloablative No > 24
13 ≥ 45 NHL Auto – – > 24
14 < 45 T-lymphoblastic lymphoma Allo Myeloablative Yes > 24
15 ≥ 45 NHL (relapsed) Auto – – < 24
Abbreviations: Pt patient, AML acute myeloid leukemia, ALL acute lymphoblastic leukemia, NK LGL leukemia natural killer cell large granular
lymphocyte leukemia, NHL non-Hodgkin lymphoma, MM multiple myeloma, Allo allogeneic stem cell transplantation, Auto autologous stem cell
transplantation, HSCT hematopoietic stem cell transplantation, GVHD graft-versus-host disease
a Only applicable to allogeneic stem cell transplantation survivors
b Intensity of the preparation regimen given directly before HSCT, a myeloablative conditioning regimen will cause pancytopenia and a stem cell support
is needed to restore bone marrow function, while a reduced intensity regimen is less intensive and only causes partial cytopenia
c Based on self-report
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Table 2 Work-related characteristics of the patients treated with HSCT
Pt Work status before diagnosis Current occupation (working hours) RTW and current work
characteristics
Occupation Years in company
before HSCT
Contract Hours Occupation Contract Hours (contract)/
currently working
1 Office manager < 5 Perm 36 Disability
pension
NA NA • Stopped working directly after
diagnosis, initial RTW
~ 10 months
later (officially sick-listed)
• Disability pension started 2 years
after diagnoses
2 Specialized
traffic
controller
≥ 5 Perm 36 Security
supervisor
Perm 36/24 (officially
sick-listed)
• Stopped working directly after
diagnosis, initial RTW between
1.5 and 2 years later
• Officially still 100% sick-listed
• Assignment to job of lower rank,
without irregular shifts
• Potential further partial loss of
income in near future
3 Sales assistant < 2 Temp 20 Disability
pension
NA NA • Stopped working directly after
diagnosis (of relapse)
• Fixed-term employment contract
was not extended
4 Customer
relationship
manager
< 5 Perm 32 Same Perm 32/32 • Officially 100% sick-listed after
diagnosis, but performed some
work tasks during the first
treatment period
• Did not work in the month
succeeding
SCT, gradual RTW hereafter
• Less and unpleasant job tasks
during
initial RTW
5 Scientist ≥ 5 Perm 40 Manager Perm 40/40 • Stopped working directly after
diagnosis,
initial RTW ~ 7 months later, full
RTW more than 1.5 year
after diagnosis
• Assignment to job of higher rank/
promotion
6 Account manager < 2 Perm 40 Same Perm 36/0 • Stopped working directly after
diagnosis, initial RTW ~ 1 year
later, full RTW 2 years
after diagnosis
• Different job tasks
• 1 year after full RTW, new period
of
sick-leave
7 Financial
employee
≥ 5 Perm 40 50% disability
pension,
50% same
Perm 40/20 • Recurrent periods of sick-leave in
the years before SCT
• 6 months after SCT initial RTW
• Less challenging job tasks
8 Warehouse
employee
≥ 5 Perm 40 Same Perm 40/40 • Stopped working after diagnosis,
initial RTW ~ 8 months later, and
full RTW 1 year after diagnosis.
• 1 month later, new period of
radiation
therapy and partly sick-listed
• Worked 100% at the time of the
interview
9 Office sales
worker
≥ 5 Perm 37.5 Disability
pension
NA NA • Before diagnosis, reintegrating and
officially 100% sick-listed because
of a shoulder injury
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facilitator. Patient 12 reported receiving autonomy from a su-
pervisor and the influence of the occupational physician on
RTW (quote 9, Table 3).
Environmental factors—not directly related to work
‘The lack of RTW support from the hospital’ was mentioned
as a barrier, while support from healthcare professionals, other
cancer survivors, and immediate family members were report-
ed as RTW facilitators. The rules and regulations were both
frequently mentioned as barriers and facilitators. For some
patients, the fear of losing their job and/or the financial con-
sequences of being on extended sick-leave urged them to
RTW. In one patient, however, this incentive made her return
too quickly, causing a (worse) recurrent sick-leave.
Solutions to improve RTW
Patients often found it difficult to identify solutions for
RTW barriers. Some patients mentioned that they would
have liked to talk about work issues at the hospital (quote
10, Table 3) and others would have liked more support from
Table 2 (continued)
Pt Work status before diagnosis Current occupation (working hours) RTW and current work
characteristics
Occupation Years in company
before HSCT
Contract Hours Occupation Contract Hours (contract)/
currently working
• Stopped reintegration trajectory
after diagnosis
• Disability pension started in month
succeeding HSCT
10 Self-employed Unknown – 65 Disability
pensiona
NA NA • Stopped working after diagnosis,
closed his company
• Plans to start a new company in
months succeeding the interview,
approximately 1.5 year after
diagnosis
11 Operator
(machine)
≥ 5 Perm 40 Same Perm 40/40 • Stopped working after diagnosis,
initial RTW ~ 1.5 year later.
Full-time available for work
at the time of the interview, but
was at least partly sick-listed
• Less satisfying job tasks, with
perspective to return to old tasks
in future
12 Health care
professional
≥ 5 Perm 24 Same Perm 24/24 • Stopped working after diagnosis,
initial RTW ~ 1 year later and
full RTW ~ 1.5 year after
diagnosis
13 Educational
professional
≥ 5 Perm 40 Same Perm 40/40 • Stopped working after diagnosis,
initial RTW ~ 10 months later
14 Self-employed Unknown – 50 Disability
pensiona/
self-employed
NA Unknown • Stopped working after
diagnosis/during
treatment, initial RTW ~ 3.5 years
later
• Family members took
over/continued
job tasks/hours
15 Advisor ≥ 5 Perm 32 Same Perm 32/32 • Worked until start of treatment, and
performed some work tasks until
hospitalization for the
transplantation
• Initial RTW ~ 2.5 month after SCT,
~ 8 months after diagnosis. Full
RTW between 1.5 and
2 years after diagnosis
Abbreviations: Pt patient, Perm permanent employment contract, Temp temporarily employment contract, RTW return to work
a Private insurance
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their employer (longer period in which the patient receives
100% of their original salary, regular meetings to discuss
RTW progress). Also, improving the opportunities to par-
ticipate in a rehabilitation or physical exercise program was
Table 3 Quotes of the patients that illustrated their work perceptions and the barriers to and facilitators for RTW they encountered after HSCT
Quote
Nr.
Pt Theme Quote phrase
1. 2 Return to work progress BWell, I – uh, let me see – started in January 2012 with two times a week for four hours,
reviewing every three months, adding two hours every time. The goal was to reach four days
by the end of this year, but that’s no longer feasible. I stopped at three days - full days – and
that has already started to become problematic.^
2 5 Work perceptions B… Look, in theory, if you’ve been this ill, you’d be better off writing a novel, or just follow your
childhood dreams. Or, at least, that aspect is almost a contingency to being that ill. However,
I realized all I wanted to do was simply go back to work.
…
Would my life have become hopeless if I wouldn’t have been able to go back to work – well
maybe that is a bit of an overstatement – but I do think work is important, probably more so
now than I would been inclined to say before I fell ill.^
3 2 Work perceptions BPreviously, you had to do everything, and I’d do it all rather quickly. Now, that’s not possible
anymore. So, under those circumstances I do not know... how am I supposed to get back to
work? How? How can I, you know, I will never be able to manage it all. Now and again, I
still consider things, but jeez.^
4 15 Looking after one’s health—facilitator—
activities and participation
Q: BAnd the exercising at ‘Herstel en Balans’ [rehabilitation program]. Has that helped you a
little in returning to work?^
R: BA little? A lot! Without that – It would have taken me another year. You really do need it. I
am not much of an athlete, so my goodness did I have an obstacle to surmount. But I still
exercise now, because I have noticed, I just have to keep doing it.^
5 14 Barrier—personal factors BPreviously, it didn’t matter to me at all, you just washed your hands and were done with it, but
now, now you think Boh no, I’ve got a tiny cut, should I touch that.^ You know, before you
know it, you’ve got another infection, which will take forever to go away.^
6 12 Barrier—personal factors BEspecially as a layman, if your whole life has been – tralala, tralalie – void of such things and
suddenly you’re confronted with such bureaucracy. And if you have to read those forms, and
– of course - they contain loads of things, which you actually don’t want to know at all. And
then you think: BGee, what am I being confronted with, while I’ve been ill and haven’t asked
for this at all.^ That’s just what I thought, I found it overwhelming.^
7 15 Barrier—environmental factors—directly
related to work
BI had allocated my work among many colleagues. And they enjoyed it. And they all said BWell,
but this is actually part of my job now.^ So I thought hold on, hold on, what is this? Yeah, or
they would just stay in a working group, or if they were asked a question they would just
answer to it. They didn’t say Bwell, [respondent] has returned to her duties, you should take
this to her.^
8 5 Barrier—environmental factors-directly
related to work
B...You’re also going to shake your respondent’s hand.Well, those are things you cannot have at
all, because I was really vulnerable. So, that was difficult. And to explain this every single
time, and every time you’re like, well, I am not going to shake your hand.^
9 12 Facilitator—factors directly related to
work
BWell, this occupational physician, − uh – I have actually set up a schedule together with him
to see what is manageable and desirable? That has helped me a lot.^
10 3 Solutions for RTW barriers BEspecially in the beginning, because you are suddenly unemployed and you don’t know what
is going to happen and you don’t know what your options and legal rights are. So, I would
have appreciated it if I could have talked about that some more, or ask some questions.^
11 2 Need for improved information BBut I also tried appealing to the UVW [Employee Insurance Agency], like so, how will things
develop in the coming period? Like, will my income decrease because of my illness? What
are you going to top up, and for how long? Because if the UVW [Employee Insurance
Agency], goes: Bwell, Mister [name of patient], your salary at the moment of being ill, well
now that you’re going back to work and your salary is lower, you have a loss of revenue
because of being ill. Well, we’re going to compensate for that. Well, then you won’t hear me
complaining. But I’ve already tried to contact them a few times, but they’ll simply reply by
telling me Bwell Mister [name of patient], you do not have priority right now. You’ve been
scheduled in December. Then I’ll say that I am aware of that, but I would like to have clarity
for myself. Because the conversations are going to happen soon, but I want to know what I
can expect.^
Abbreviations: Nr number, Pt patient
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mentioned. Many patients reported the need for information
about the financial consequences of being on sick-leave,
long-term disability, and the rights and rules when sick-
listed (quote 11, Table 3).
Discussion
This qualitative study explored work perceptions, barriers to,
and facilitators of RTW, and possible solutions to improve
Table 4 Work perceptions of the 15 HSCT survivors that participated in our study
RTW motivations
• Not wanting to be at home/getting out and about
• Wanting distraction
• Live up to expectations of society
• Not wanting to be a patient anymore
• Returning to work as proof of recovery
• Having positive work ethos:
○ Not wanting to be on benefits
○ Feeling commitment toward society at large
• Not wanting to run into financial difficulties
Work values
• Work as a goal in life
• Mean something
• Return to society
• Altered work values:
○ Health and family more important
○ Resignation about work future
○ Less easily concerned about work future
Perceived work ability
• Being able to meet work demands
• Being realistic about own work ability
• Experiencing not being able to/having trouble with meeting work demands due to:
○ Recovery time needed/interference with social/family life
○ Long-term side effects of diagnosis and treatment
• Being uncertain about own work ability
Feelings about (not being able) (to return to) work
• Acceptance of health limitations that interfere with
(being able to) work
• Enjoy working
• Negatively altered relationships at work
• Being officially work disabled felt as being of no account
• Returning to work felt as a lonely process
Table 5 Facilitators for and barriers to RTW categorized according to the ICF
ICF domain ICF factor Barrier (−)/facilitator (+)
Disease/disorder and body functions, body structure (Duration of) cancer treatment and appointments at outpatient clinic –
(Absence of) long-term side effects of hematologic
cancer treatment and medication
−/+
Temperament and personality functions −/+
Comorbidity and pre-diagnosis poor health –
Activity/participation Looking after one’s health +
(Having difficulties) with economic self-sufficiency −/+
Having difficulties commuting –
Having difficulties with doing household tasks
including taking care of children
–
Personal factors (Not) having adequate skills/competences −/+
(Not) having difficulties coping −/+
(Negatively altered) importance of work −/+
Environmental factors—directly related to work Negative/positive job content −/+
Negative/positive work conditions −/+
Negative/positive terms of employment −/+
(Absence of) support and understanding supervisor −/+
(Absence of) support and understanding colleagues −/+
(Absence of) support and understanding occupational physician −/+
(Absence of) support and understanding human
resource management
−/+
Support and understanding customers +
Keeping in touch with workplace +
Environmental factors—not directly related to work (Absence of) support and relationship—health professionals −/+
Support and relationship—former cancer patients +
Support and relationship—immediate family +
Service systems and policies −/+
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RTW among HSCT survivors. At a mean 2.5 years after
HSCT, approximately half of the patients had not or only
partially returned to work. Most HSCT survivors valued work
as positive and they were motivated to RTW. Still, RTW was
often a long-lasting process associated with many perceived
uncertainties about RTWand the associated financial aspects.
These findings indicate the need for RTW support for HSCT
survivors before, during, and after initial RTW.
Work perceptions
Most patients were very motivated to RTW, and for many
patients work was an important topic in their lives. Despite
the distinctive aggressiveness of the HSCT and the higher
risks on medical complications and symptoms when com-
pared to other cancer treatments [2], these and the other men-
tioned work perceptions were comparable to those found in
meta-syntheses in which the qualitative literature on the expe-
riences with work of survivors of various types of cancer had
been reviewed [15, 16]. Consequently, work perceptions seem
to be generalizable across different populations of cancer
patients.
Despite the similarities across populations, work percep-
tions differed considerably at the individual level. For in-
stance, for some patients, the positive feelings about work
stood out, while for others negative feelings were evident.
Tiedtke et al. [26] suggested that different experiences likely
influence what type of support is warranted. Therefore, when
advising patients on RTW, and/or when advising health care
professionals, supervisors, or colleagues on how they can sup-
port an employee/colleague diagnosed with cancer, it appears
to be more important to focus on individual work perceptions,
rather than assuming differences in work perceptions based on
their cancer type and/or treatment.
Barriers to and facilitators of RTW and possible
solutions to improve RTW
The patients in our study were unable to work during at least a
part of the treatment, and it often took months to (partially)
RTW. This can be explained by the distinct aggressiveness of
this type of treatment and its frequent medical complications
(e.g., infections and/or graft-versus-host-disease). Our study
corroborates findings from previous studies among patients
treated for a hematologic malignancy that ongoing physical
and psychological problems are barriers to RTW [17, 18]. It
furthermore corroborates findings from employers’ and survi-
vors’ perspective that support of the employer and of col-
leagues, as well as flexible working hours and work tasks/
conditions are important facilitators of RTW [27, 28].
Similarly, it supports previous findings among cancer patients
that report on the importance of personal factors such as cop-
ing and self-efficacy [29]. In addition, and in line with
previous studies [15–18], the financial impact of being sick-
listedwas important for our patients. The (fear of the) financial
consequences of being sick-listed and being assessed for a
disability pension were experienced as RTW facilitator.
Although the existence of a financial incentive to RTWmight
be positive for some patients, our study showed that it be-
comes problematic when patients are forced to RTW while
they are physically and/or psychologically unable to perform
the job tasks, posing the patients at risk for recurrent sick-
leave. Unfortunately, this issue is difficult to overcome, as it
is a consequence of national laws and regulations.
There were some discrepancies between our findings and
those reported previously. First, in contrast to a previous qual-
itative study among patients with hematologic malignancies
[18], our patients did not mention approval for RTW provided
by the hematologist as a facilitator for RTW. However, talking
about work issues in the hospital and improved support and
information about sick-leave, disability pension and RTW
were identified as potential solutions to improve RTW.
Tamminga et al. [30] did not find favorable effects of a
hospital-based work support intervention when compared to
usual care on RTW outcomes, QoL, and work ability among
133 breast and gynecological cancer patients, although the
intervention was considered useful by the intervention pro-
viders (nurses) and was appreciated by patients. It is yet un-
clear whether addressing RTW barriers by the hematologist,
specialist nurse, or social worker would improve RTW of
HSCT survivors.
Second, inconsistent with the findings of previous studies
[15–17], our patients did not mention problems with disclos-
ing the diagnosis to colleagues and employers. It could be that
the patients had no other option: The small timeframe between
diagnosis and start of treatment and/or the required hospital
admission might have forced patients to disclose the diagno-
sis. Still, also the Dutch social security system in which em-
ployees are protected against dismissal due to illness might
play a role [21]. In four other Dutch qualitative studies on
work experiences of in total 72 cancer patients (breast cancer:
n = 41) [21, 31–33], only one study reported that some pa-
tients did not want to disclose their disease to colleagues [31].
Third, the perceived importance of looking after one’s
health, and specifically the participation in rehabilitation pro-
grams or sports as facilitator for RTW have not been reported
previously in patients with hematologicmalignancies [17, 18],
nor in the previous reviews [15, 16], but had been mentioned
earlier by Dutch cancer survivors [21, 33]. Additionally, pos-
sible positive effects of exercise on RTW have been reported
in qualitative studies among cancer patients who had partici-
pated in an exercise program [32, 34]. Currently, however,
only a few RCTs have evaluated the effects of a physical
exercise/activity intervention on RTW, with conflicting results
[35, 36]. In their Cochrane review, De Boer et al. [37] found
moderate quality evidence that interventions in which
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vocational counseling is combined with patient education, pa-
tient counseling, and biofeedback-assisted behavioral training
or physical exercise, result in higher RTW rates. Further reha-
bilitation trials might therefore consider including vocational
counseling in their intervention program and to include RTW
as secondary outcome measurement.
Strengths and limitations
A strength of this study is the inclusion of a heterogeneous
study population in terms of pre-diagnosis working situation,
RTW trajectories, and physical health. This provides a broad
perspective of the barriers to and facilitators of RTW that HSCT
survivors perceive. Furthermore, the use of themes from an
overview of issues that might contribute to the quality of work-
ing life of employees with a chronic disease [23] and the ICF
model [24] resulted in a structured overview of the results and
allows comparison with other studies. A limitation of this qual-
itative study is the fact that we did not check for data saturation.
Therefore, it might be that saturation was not reached, and
additional interviews could have resulted in new themes.
However, our results could be used as a starting point for the
development of questionnaires, studying (return to) work per-
ceptions, and barriers to and facilitators of RTWof HCTS sur-
vivors, which could be administered to a large and representa-
tive sample. Furthermore, in the fourth step of the analysis (i.e.,
when open codes were classified into the ICFmodel), we used a
deductive coding technique. It is possible that a different clas-
sification of barriers to and facilitators of RTW had emerged, if
we had developed a new model based on our open codes.
However, the use of existing models enables comparison with
other studies and resulted in a structured overview.
Another limitation is the fact that there is still a need for a
prospective cohort study to determine which of the perceived
barriers and facilitators are actual predictors of RTWoutcomes
and to determine which of the suggested solutions to improve
RTWmight actually improve RTW. Non-amendable predictors
(e.g., age) could provide us insight which population is at risk
of adverse RTW outcomes. Modifiable predictors (e.g., em-
ployer support) and suggested solutions to improve RTW could
yield insight into which factors should be targeted by an inter-
vention program or policy, or what the content of such an in-
tervention program or policy should be.
In conclusion, this qualitative study showed that many
HSCTsurvivors value work as positive and they are motivated
to RTW. Still, RTWwas often a lengthy and complex process.
Insight in work perceptions, RTW barriers, and solutions
might help researchers, healthcare professionals, and em-
ployers to develop and/or tailor individualized multidisciplin-
ary care to facilitate RTW.
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